Interviews on biotechnology

Interview 22 Feb 2021

How Automation Can Augment Drug Discovery Research

Robotics and artificial intelligence are rapidly changing the way we discover drugs. Martin-Immanuel Bittner, CEO and co-founder of Arctoris, discusses the benefits and challenges of introducing automation in drug discovery efforts. The Oxford-based startup Arctoris was established in 2016 with the objective of offering remote access to automated drug discovery. At a time when researchers […]

February 22, 2021 - 8 minutesmins - By External Contributor

Interview 1 Feb 2021

Democratized DNA Synthesis: A Game-Changer Against Covid-19

DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions during lockdowns. Thomas Ybert, CEO of DNA Script, discusses the French company’s plans to protect research from future disruptions by giving every lab the ability to synthesize its own DNA molecules. The Covid-19 pandemic has highlighted more than ever the […]

February 1, 2021 - 6 minutesmins - By Jonathan Smith

Interview 23 Nov 2020

CDMOs Are the Unsung Heroes of the Gene and Cell Therapy Revolution

Cell and gene therapy is booming amid the ongoing pandemic, and this is driving up demand for synthetic DNA products, often produced and delivered by CDMOs. Karen Fallen started her career at Celltech Biologics in the UK, which was acquired in 1996 by Swiss giant Lonza, a world leader in the pharmaceutical manufacturing space. She […]

November 23, 2020 - 5 minutesmins - By Helen Albert

Interview 28 Oct 2020

Do Natural Killer Cells Hold the Key to Treating Blood Cancers?

Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come with a number of setbacks, such as long timelines and serious adverse reactions. As CEO of the Dutch biotech Kiadis Pharma, Arthur Lahr has been leading the development of a technology that could overcome these limitations by using natural killer […]

October 28, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

Interview 5 Oct 2020

How is Germany Meeting Patient Demand for Medical Cannabis?

Since Germany legalized cannabis for medical use in 2017, we have frequently spoken to Peter Homberg, Partner and Head of the German Life Sciences Practice and the European Cannabis Group at Dentons, a global law firm. Over the years, Peter has provided us with regular updates on the European and German medical cannabis industry. In […]

October 5, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

Interview 28 Sep 2020

From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah

Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood cancer, has revolutionized both oncology and gene therapy. Gaurav Shah, now CEO of Rocket Pharmaceuticals, led the team that developed it. Shah began his career as a clinician, but soon moved over into the biotech sector to work at ImClone, […]

September 28, 2020 - 9 minutesmins - By Helen Albert

Interview 9 Sep 2020

Biotech Investment in Norway: An Alternative Approach

Norway has not typically been an attractive region for biotech investors, so when Masha Strømme set up her own investment firm in 2008, she had to take a slightly different approach to investment. Masha Strømme and her husband, Dag Strømme, run a family office together called Paacs Invest in the Oslo area, which funds and […]

September 9, 2020 - 6 minutesmins - By Helen Albert

Interview 2 Sep 2020

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

For decades, Alzheimer’s disease research focused on a hypothesis that has increasingly been contested. A team of scientists in Slovakia has been swimming against the tide since the beginning, going for an alternative approach that has only recently started gaining recognition. Research in Alzheimer’s disease has recently been plagued by intense disappointment. For over 25 […]

September 2, 2020 - 8 minutesmins - By Farhan Mitha

Interview 29 Jul 2020

Medical Cannabis: Regulatory Issues, Patient Demand, and Pricing Changes in Germany

While the coronavirus pandemic has shaken many industries to their core, the European medical cannabis industry continues to flourish. A number of recent developments in Germany show that the demand for medicinal cannabis is growing. But the German medical cannabis industry is also facing a number of challenges, including an unmet patient demand and a […]

July 29, 2020 - 8 minutesmins - By Larissa Warneck-Silvestrin

Interview 21 May 2020

What 2019 Can Teach About European Biotech Investments Going Forward

Following 2018’s bumper harvest for equity funding in European biotech, 2019 proved even more lucrative, particularly for private biotech companies. What are the biggest investment lessons learned from 2019, and how could Covid-19 change the dynamic in 2020? With the coronavirus pandemic thrusting global industry sectors into chaos, investors and entrepreneurs need to understand the […]

May 21, 2020 - 9 minutesmins - By Jonathan Smith

Interview 15 Apr 2020

Investing in the Microbiome in the Age of Covid-19 and Beyond

For Isabelle de Cremoux, CEO and Managing Partner at Seventure Partners, 2020 was going to be an important year for microbiome research. However, the global coronavirus pandemic arrived, presenting one of the greatest unforeseen challenges in human history. I spoke to her about the microbiome field’s progress and the legacy of the Covid-19 pandemic going […]

April 15, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

Interview 23 Mar 2020

Riding the Wave of Cambridge Entrepreneurship

The University of Cambridge is world-famous, but unlike its US equivalent, the city isn’t as well known for its startup culture. Jason Mellad, CEO of StartCodon — a new accelerator based there — believes the area is a great place to set up a new biotech. “When I arrived in 2004, there were several people, […]

March 23, 2020 - 9 minutesmins - By Helen Albert

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us